In the January / February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts on how to make the clinical trial process more efficient, easier and accessible to a wider group of patients.
“It’s about making the neighborhood doctor a key opinion leader who can educate and inform within the community,” says David Fleishman, chief operations officer, BBK Worldwide. “It’s about selecting the right location for the study site—not because there is a high patient population, but because it is an area where patients are going to be more comfortable about pursuing the care they need. And it’s about ramping up support services that address some of the common concerns that may interfere with participation, such as childcare, meal preparation, transportation and lost wages.”
Click here to read the entire article in PM360.